These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19382502)

  • 1. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study.
    de Gussem EM; Snijder RJ; Disch FJ; Zanen P; Westermann CJ; Mager JJ
    Rhinology; 2009 Mar; 47(1):85-8. PubMed ID: 19382502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
    Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
    Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Lennox PA; Hitchings AE; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent nosebleeds in patients with hereditary hemorrhagic telangiectasia].
    Slotosch D; Koller M; Werner JA; Folz BJ
    Dtsch Med Wochenschr; 2006 Mar; 131(11):535-9. PubMed ID: 16538555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.
    Simonds J; Miller F; Mandel J; Davidson TM
    Laryngoscope; 2009 May; 119(5):988-92. PubMed ID: 19194865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia.
    Al-Deen S; Bachmann-Harildstad G
    Rhinology; 2008 Dec; 46(4):281-4. PubMed ID: 19145996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease.
    Folz BJ; Tennie J; Lippert BM; Werner JA
    Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.
    Mardikian PN; LaRowe SD; Hedden S; Kalivas PW; Malcolm RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):389-94. PubMed ID: 17113207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
    Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
    Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Levine CG; Ross DA; Henderson KJ; Leder SB; White RI
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):721-4. PubMed ID: 18503842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.